In Depth
Clinical tips: antibiotic resistance
Louis Roller takes a look at the threat of antibiotic resistance “…this serious threat is no longer a prediction for the future; it is happening right now in every region …
The wrong decision?
Some thoughts on the proposed rescheduling of OTC Codeine-containing products to Prescription Only, by Professor Peter Carroll In the current debate regarding the proposed rescheduling of over the counter (OTC) …
Opinion: Why we need a National Poisons Law
Prescribers and pharmacists have their time wasted trying to negotiate the red tape for their patients, writes Andrew Tooms Introduction We have in Australia six States that at federation in …
Research Roundup
Debbie Rigby rounds up the latest in research news Vitamin D supplementation to prevent asthma exacerbations A systematic review and meta-analysis of individual participant data (n=955) has concluded that Vitamin …
Future bound
Moving pharmacy to the next phase of its existence means turning uncertainty into opportunity, says John Thornett Whilst pharmacy is undergoing yet another review, the uncertainty of the future of …
Clinical tips: the ‘worried unwell’
Karalyn Huxhagen takes a look at supporting patients with low health literacy and limited health professional access We have all met the “worried well”. These are the customers who give …
The peak time for asthma
Act now to help your patients with asthma navigate allergy season, writes Stephenie Shea Asthma is a common chronic condition of the airways, where one in nine Australians are affected—that’s …
Research Roundup
Debbie Rigby takes a look at the latest in research news Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations Onabotulinum toxin A (BoNT-A) is …
Making the most of the upcoming peak period
What’s in a name? There are some key acronyms you need to remember to get your pharmacy fully geared up for the peak season, says Glenn Guilfoyle As pharmacy owners, …
Dying a good death: what we need from drugs that are meant to end life
Dying a good death: what we need from drugs that are meant to end life Betty Chaar, University of Sydney and Sami Isaac, University of Sydney Generally speaking, health care …
Why pharmacy must embrace technology
New technologies offer a lot to the emerging generation of young pharmacists, writes Shefali Parekh We are well and truly in the digital age, and technology has a lot to …
Research Roundup
Debbie Rigby takes a look at the latest in research news Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events A large cohort study of over 600,000 people aged 40 and …